TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AstraZeneca to cut 1,600 in U.S., U.K.

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | Photo Reprints

AZN $46.18 -$0.28

at close on MONDAY


By The Associated Press

Published: Tuesday, March 19, 2013, 12:01 a.m.

Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the United States and United Kingdom, as its new CEO starts a major research and development reorganization.

The cuts come just weeks after the company reported big drops in revenue and net income for 2012 and forecast continuing difficulties as generic competition hurts sales.

The job reductions amount to nearly 3 percent of AstraZeneca's 57,200 workers.

worldwide and are part of moves affecting several major AstraZeneca sites in the UK, US and Sweden.

Even the global headquarters will be shifted, from London to Cambridge, England, as the company moves many of its scientists near top centers for bioscience research. Rivals have been doing the same, to be near those talent pools and to increase collaborations with scientists at universities and small biotech companies.

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Consider carefully details, people involved in financial trust
  2. More women seize opportunities to start businesses
  3. Meat prices drain barbecue budgets
  4. Is tech wreck  on way?
  5. Wages have soared in Pittsburgh, but economy appears to have stalled
  6. ‘Sweet spot’ mid-cap stocks worthy of investor affection
  7. Investment in Western Pa. startups reaches 5-year high
  8. Consol Energy transitions as leadership changes hands
  9. Lawsuit challenges Hollywood standard of unpaid internships
  10. Pa. unemployment rate falls to lowest since 2008; 12,000 more enter workforce
  11. Low pay, commutes among top stressors
Subscribe today! Click here for our subscription offers.